医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

HCCA named Best Emerging IT-BPM Company for Healthcare at International ICT Awards Philippines

2016年04月11日 PM11:00
このエントリーをはてなブックマークに追加


 

NASHVILLE, Tenn.

HCCA, which provides a full spectrum of URAC-accredited Clinical Process Outsourcing (CPO) services, was named Best Emerging IT-BPM Company for Healthcare at the annual International ICT Awards held recently in Manila, the Philippines.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160411005207/en/

The HCCA team celebrates being named Best Emerging IT-BPM Company for Healthcare at the annual Inter ...

The HCCA team celebrates being named Best Emerging IT-BPM Company for Healthcare at the annual International ICT Awards in Manila, the Philippines.

The International ICT Awards recognize the most successful companies in the information technology-business process management (IT-BPM) industry with an emphasis on stimulating dynamic growth and new developments. Launched in 2007, the International ICT Awards is organized by the Canadian Chamber of Commerce in cooperation with the IT-Business Process Association of the Philippines (IBPAP).

Based in Nashville, HCCA was originally established to recruit and deploy highly experienced nurses and other medical professionals to hospitals around the world. Today, HCCA offers a full spectrum of URAC-accredited CPO services to clients in the United States, improving results and efficiency through medical management, medical coding, workers’ compensation, nurse first response, and U.S nurse staffing.

HCCA’s blended outsourcing capabilities provide a key advantage. The company uses top-quality medical professionals to supplement or manage existing healthcare processes. HCCA is experienced in partnering with healthcare clients to deliver consistent results through its high-caliber clinical staff and a flexible, scalable business model that caters to specific customer needs. The Philippines provides HCCA with a rich talent pool to serve its customers.

“This award encourages us to continuously live our commitment to supporting the healthcare industry with intelligent, patient-centered clinical process outsourcing solutions that improve competency for health care providers,” said David Bartholomew, President and Chief Executive Officer of HCCA.

“This is a proud moment for our organization, and we are thankful for the trust and dedication of our customers, employees, and partners,” said Anshum Sinha, Country Manager and Vice President for Philippines Operations of HCCA. “We are delighted with the rapid progress of HCCA in the Philippines and our exceptional success rate in recruiting Filipino nurses not just for placement in CPOs in-country but also in U.S. hospitals.”

About HCCA

HCCA’s global headquarters is located in Nashville, Tennessee. A URAC-accredited provider of domestic and offshore Clinical Process Outsourcing (CPO) services, it has been leveraging its international expertise since 1973 when HCCA was established as HCA’s international provider division. For over 40 years, HCCA has been one of the largest global employers of nurses and other healthcare workers from the Philippines. HCCA’s unique CPO model was developed with the objective of combining clinical expertise with business acumen to improve efficiency and deliver the highest quality of service and care.

For more information, please visit: www.hccahc.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160411005207/en/

CONTACT

HCCA
John Hannon, 615-921-9441

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease